# Organ Preservation in Locally Advanced Rectal Cancer by Radiochemotherapy Followed by Consolidation Chemotherapy.

> **NCT03561142** · PHASE2 · UNKNOWN · sponsor: **University Hospital Tuebingen** · enrollment: 94 (estimated)

## Conditions studied

- Rectal Cancer
- Rectal Neoplasms
- Rectal Cancer Stage II
- Rectal Cancer Stage III

## Interventions

- **RADIATION:** Radiotherapy
- **DRUG:** Chemotherapy
- **OTHER:** Deep regional hyperthermia

## Key facts

- **NCT ID:** NCT03561142
- **Lead sponsor:** University Hospital Tuebingen
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-06-15
- **Primary completion:** 2020-04-16
- **Final completion:** 2024-04-16
- **Target enrollment:** 94 (ESTIMATED)
- **Last updated:** 2018-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03561142

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03561142, "Organ Preservation in Locally Advanced Rectal Cancer by Radiochemotherapy Followed by Consolidation Chemotherapy.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03561142. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*